| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 27,325 | 30,325 | ||
| General and administrative | 13,211 | 12,608 | ||
| Total operating expenses | 40,536 | 42,933 | ||
| Loss from operations | -40,536 | -42,933 | ||
| Fair value change of warrant liabilities | 101,318 | 2,540 | ||
| Benefit from r&d tax credit | -3,924 | -4,287 | ||
| Interest income | 1,588 | 1,898 | ||
| Foreign exchange (losses) gains | -883 | 2,349 | ||
| Interest expense | 1,105 | 1,151 | ||
| Other income | 383 | -176 | ||
| Total other income, net | -97,411 | 4,667 | ||
| Loss before income taxes | -137,947 | -38,266 | ||
| Income tax benefit (expense) | -230 | 137 | ||
| Net loss | -137,717 | -38,403 | ||
| Foreign exchange translation adjustment | -605 | 1,729 | ||
| Comprehensive loss | -138,322 | -36,674 | ||
| Net loss per share attributable to ordinary shareholders - basic (in dollars per share) | -1.44 | -0.41 | ||
| Net loss per share attributable to ordinary shareholders - diluted (in dollars per share) | -1.44 | -0.41 | ||
| Weighted average ordinary shares outstanding - basic (in shares) | 95,337,993 | 93,341,594 | ||
| Weighted average ordinary shares outstanding - diluted (in shares) | 95,337,993 | 93,341,594 | ||
COMPASS Pathways plc (CMPS)
COMPASS Pathways plc (CMPS)